Hip Activation vs. Hip Activation + Core Stabilization (NCT06260306) | Clinical Trial Compass
CompletedNot Applicable
Hip Activation vs. Hip Activation + Core Stabilization
United States34 participantsStarted 2024-01-24
Plain-language summary
The purpose of this investigation is to compare the effects of a combined hip activation and core stabilization training home exercise program (HEP) versus a hip activation training HEP alone on lower extremity (LE) frontal plane mechanics in healthy individuals.
Specific Aim 1: To determine whether between- and/or within-group differences exist on the Forward Step-Down test (FSDT) when comparing a combined hip activation and core stabilization training HEP as compared to a hip activation training HEP.
Specific Aim 2: To determine whether between- and/or within-group differences exist on the peak external knee abduction moment when comparing a combined hip activation and core stabilization training HEP to a hip activation training HEP.
Specific Aim 3: To determine whether between- and/or within-group differences exist on gluteal and core muscle surface electromyography (sEMG) when comparing a combined hip activation and core stabilization training HEP to a hip activation training HEP.
Specific Aim 4: To determine whether a dose-response relationship exists between HEP compliance and change on the FSDT, peak external knee abduction moment, and sEMG.
Who can participate
Age range
22 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participants will be current first- or second-year Doctor of Physical Therapy (DPT) students in the School of Allied Health Professions (SAHP) at Louisiana State University Health Shreveport over the age of 21.
Exclusion Criteria:
* Current pain or pathology in either LE which currently limits their ability to perform the FSDT or drop landing task, a history of low back pain in the last three months, known pregnancy, as pregnancy is a risk factor for diastasis rectus abdominis (DRA) which may be exacerbated by participation in the intervention and could be a confounding variable, and current participation in other clinical trials.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial compared hip activation alone versus hip activation combined with core stabilization exercises — based on my specific lower extremity problem, which of those two approaches does my doctor think would be more appropriate for me?
2The trial used the Forward Step Down Test to measure outcomes, which assesses how well someone controls movement during a step-down motion — does my doctor think my current movement patterns would be captured well by that kind of assessment, and could it help guide my treatment?
3Since this trial has already been completed, has my doctor seen or reviewed any of its findings, and do the results suggest one exercise approach showed a meaningful advantage over the other for people with my condition?
4This study didn't involve a drug or device, just exercise-based interventions — would my doctor recommend I try one of these approaches as part of my current care plan, or is there a different first-line treatment I should consider before exploring what this trial tested?
5Because this was a non-drug exercise trial with no assigned phase, what does my doctor know about the safety profile of hip activation and core stabilization programs for someone with my specific lower extremity issue?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Forward Step Down Test (FSDT)
Timeframe: Pre- and post-eight week intervention
Trial details
NCT IDNCT06260306
SponsorLouisiana State University Health Sciences Center Shreveport